$Clearmind Medicine(CMND.US$ 如果您對股價的這一小幅波動感到興奮,而且您擁有大量的股票,那就不要這只是對最新的專利獲得批准的反應。在您看到真正的利潤之前,這是 10 到 20 年的保留時間。該公司或 Pathways 將是第一家獲得廣泛點差使用批准的公司,但至少不會在 5 到 10 年內,然後獲得良好的收益,然後賣掉。所以加載但要聰明不要賣出,因為股票價格...
已翻譯
4
$以星航運(ZIM.US$
ZIM is on a run today with 5.4 shares I profited $14 in one day. They're looking extremely good for their earnings coming in a week and all their financials are amazing with a 114.6% div/yeild this company is a must buy many shares
ZIM is on a run today with 5.4 shares I profited $14 in one day. They're looking extremely good for their earnings coming in a week and all their financials are amazing with a 114.6% div/yeild this company is a must buy many shares
![圖片](https://ussnsimg.moomoo.com/sns_client_feed/73664316/20240510/1715284302454-random2436-73664316-android-org.jpeg/thumb?area=100&is_public=true)
![圖片](https://ussnsimg.moomoo.com/sns_client_feed/73664316/20240510/1715284303514-random5875-73664316-android-compress.jpg/thumb?area=100&is_public=true)
2
Uncle Doug
評論了
$Clearmind Medicine(CMND.US$ 不要賣出你的職位,這家公司一定會繼續購買或持有你的股票。在他們完成了 MEAI 臨床半期的臨床試驗後,至少 6 個月到一年,它將獲得批准它有效(不要大膽發言),然後他們會開始處理它,但現在將有點買入,這家公司有巨大的成長潛力,我認為這家公司的成長潛力很大,我認為這家公司...
已翻譯
2
7
Uncle Doug
評論了
$Clearmind Medicine(CMND.US$ 我在 1 月中旬以 1.40 美元左右的價格做到這一點,一直在等待它做到什麼。讓我們希望這件事終於起飛!
已翻譯
1
3
$Clearmind Medicine(CMND.US$
26 個股份,繼續購買更多。我已經在這家公司完成了家庭作業,當他們完成試驗並獲得澳元的藥物獲得批准後,它將成為對抗酒精中毒的新奇妙藥物,更要提到當他們獲得 MDMA 藥物批准後,當他們獲得了 PTSD 藥物的批准時,他們的股價將比 2021 年底更高,到那時我將持有一小財富。這...
26 個股份,繼續購買更多。我已經在這家公司完成了家庭作業,當他們完成試驗並獲得澳元的藥物獲得批准後,它將成為對抗酒精中毒的新奇妙藥物,更要提到當他們獲得 MDMA 藥物批准後,當他們獲得了 PTSD 藥物的批准時,他們的股價將比 2021 年底更高,到那時我將持有一小財富。這...
已翻譯
2
$Clearmind Medicine(CMND.US$ 46... total P/L today 6.66 26 shares & counting. i believe that this kind of net gen medications are needed to treat mental illness in this country especially because I suffer from PTSD from gun violence and I had an MDMA treatment & I've never been better. This company has the means, the investors to fund their continued R&D & 3 payents have made it through phase 2 clinical trials one has finished phase 3 they are not far from becoming the 1st company to develop an...
2